HomeNewsTrendsHealth100 crore Covid vaccines administered: Survey finds 61% Indian citizens willing to take third dose

100 crore Covid vaccines administered: Survey finds 61% Indian citizens willing to take third dose

About 27 percent of respondents in a LocalCircles Survey said they would want a third dose only if COVID-19 is or likely to become prevalent at the time of availability of the third dose.

One Billion Vaccine doses, 100-crore vaccine dose, third dose, COVID-19 / October 21, 2021 / 12:30 IST
Story continues below Advertisement
Source: AP
Source: AP

As India achieved the 100 crore COVID-19 vaccine doses milestone, at least 61 percent of citizens have expressed willingness to take the third dose of COVID-19 vaccine, if available, in the next six months, a survey has found.

Another 27 percent of respondents said they would want a third dose only if COVID-19 is or is likely to become prevalent at the time of availability of the third dose. Only six percent of citizens said they do not want to take the third dose, according to the findings of the survey by LocalCircles.

Story continues below Advertisement

READ:Government to mark big billion jabs milestone with India's largest khadi tricolour, illumination, song

The survey received 9,245 responses from citizens residing in 301 districts of India. While 68 percent of respondents were men 32 percent were women. Around 43 percent of respondents were from tier 1 cities,29 percent from tier 2 and 28 percent from tier 3, 4 and rural districts.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show